Eden Research (LON:EDEN) Trading Up 31% – Time to Buy?

Eden Research plc (LON:EDENGet Free Report) shares were up 31% during trading on Wednesday . The company traded as high as GBX 4.39 ($0.06) and last traded at GBX 4.39 ($0.06). Approximately 1,139,355 shares traded hands during trading, an increase of 69% from the average daily volume of 675,899 shares. The stock had previously closed at GBX 3.35 ($0.04).

Eden Research Stock Performance

The company has a market capitalization of £21.33 million, a PE ratio of -14.01 and a beta of 0.92. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.42 and a current ratio of 3.80. The stock’s fifty day simple moving average is GBX 2.82 and its 200-day simple moving average is GBX 3.44.

Eden Research (LON:EDENGet Free Report) last released its earnings results on Tuesday, May 6th. The company reported GBX (0.36) ($0.00) earnings per share for the quarter. Eden Research had a negative return on equity of 11.63% and a negative net margin of 38.70%. As a group, equities analysts predict that Eden Research plc will post -66.0000038 earnings per share for the current year.

Insider Activity

In other news, insider Alexander John Abrey bought 167,947 shares of the firm’s stock in a transaction dated Tuesday, March 4th. The stock was bought at an average price of GBX 3 ($0.04) per share, for a total transaction of £5,038.41 ($6,705.36). Also, insider Sean M. Smith bought 426,986 shares of the company’s stock in a transaction on Tuesday, April 1st. The shares were acquired at an average cost of GBX 234 ($3.11) per share, for a total transaction of £999,147.24 ($1,329,714.19). Insiders own 14.02% of the company’s stock.

Eden Research Company Profile

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.

Featured Articles

Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.